{"id":59789,"date":"2024-08-01T13:04:26","date_gmt":"2024-08-01T11:04:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/"},"modified":"2024-08-01T13:04:26","modified_gmt":"2024-08-01T11:04:26","slug":"lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/","title":{"rendered":"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024"},"content":{"rendered":"
\n

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (\u201cLENSAR\u201d or \u201cthe Company\u201d), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the Company\u2019s second quarter 2024 financial results will be released before market open on Thursday, August 8, 2024. LENSAR\u2019s management will host a conference call and webcast at 8:30 am ET on Thursday, August 8, 2024 to discuss the financial results and recent corporate highlights.<\/p>\n

<\/a>
<\/a><\/p>\n

\nTo participate by telephone, please dial (800) 274 8461 (Domestic) or (203) 518 9848 (International). The conference ID is LENSAR. To access the live webcast, please go to the Investors section of LENSAR\u2019s website at www.lensar.com<\/a>. Following the live webcast, an archived version of the call will be available on the website.<\/p>\n

\nAbout LENSAR<\/b><\/p>\n

\nLENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the cataract procedure. LENSAR has developed its ALLY\u00ae<\/sup> Adaptive Cataract Treatment System as a compact, highly ergonomic system utilizing an extremely fast dual-pulse laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR\u2019s advanced technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reducing overhead. ALLY includes LENSAR\u2019s proprietary Streamline\u00ae<\/sup> software technology, which is designed to guide surgeons to achieve better outcomes.<\/p>\n

Contacts<\/b> <\/p>\n

\nThomas R. Staab, II, CFO
\n
ir.contact@lensar.com<\/a><\/p>\n

\nLee Roth \/ Cameron Radinovic
\n
Burns McClellan for LENSAR
\n
lroth@burnsmc.com<\/a> \/
\n
cradinovic@burnsmc.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (\u201cLENSAR\u201d or \u201cthe Company\u201d), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the Company\u2019s second quarter 2024 financial results will be released before market open on Thursday, August 8, 2024. LENSAR\u2019s management will host a conference call and webcast … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59789","6":"format-standard","7":"category-industry"},"yoast_head":"\nLENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (\u201cLENSAR\u201d or \u201cthe Company\u201d), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the Company\u2019s second quarter 2024 financial results will be released before market open on Thursday, August 8, 2024. LENSAR\u2019s management will host a conference call and webcast ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-01T11:04:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240731564545\/en\/2202372\/22\/LNSR_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024\",\"datePublished\":\"2024-08-01T11:04:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/\"},\"wordCount\":274,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240731564545\\\/en\\\/2202372\\\/22\\\/LNSR_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/\",\"name\":\"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240731564545\\\/en\\\/2202372\\\/22\\\/LNSR_Logo.jpg\",\"datePublished\":\"2024-08-01T11:04:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240731564545\\\/en\\\/2202372\\\/22\\\/LNSR_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240731564545\\\/en\\\/2202372\\\/22\\\/LNSR_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/","og_locale":"en_US","og_type":"article","og_title":"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Pharma Trend","og_description":"ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (\u201cLENSAR\u201d or \u201cthe Company\u201d), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the Company\u2019s second quarter 2024 financial results will be released before market open on Thursday, August 8, 2024. LENSAR\u2019s management will host a conference call and webcast ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/","og_site_name":"Pharma Trend","article_published_time":"2024-08-01T11:04:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240731564545\/en\/2202372\/22\/LNSR_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024","datePublished":"2024-08-01T11:04:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/"},"wordCount":274,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240731564545\/en\/2202372\/22\/LNSR_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/","url":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/","name":"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240731564545\/en\/2202372\/22\/LNSR_Logo.jpg","datePublished":"2024-08-01T11:04:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240731564545\/en\/2202372\/22\/LNSR_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240731564545\/en\/2202372\/22\/LNSR_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lensar-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59789"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59789\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}